glp 1 medicaid Patients Face New Barriers for GLP-1 Drugs State Medicaid Programs Increasingly Opting

Read the Houston Chronicle's full investigative series on Houston-based Empower Pharmacy, one of the largest compounding pharmacies in the U.S.

Official supply shortages persisted for most of 2024, as surging demand for AOMs continued to outstrip product supply, despite limited reimbursement, which presented an opportunity quickly seized upon by U.S

Given the potential for increased INR variability, clinicians may consider increasing INR monitoring frequency following GLP-1 RA initiation.

Future looks bright, healthy & lean!

Lively's HSA Spend Report shows consumers are increasingly using accounts for online wellness, mental health, and weight-loss products.